Sinsin Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	73,274	88,899	82,376	94,664	84,651	97,850
Market Cap Growth	-22.97%	7.92%	-12.98%	11.83%	-13.49%	-29.43%
Enterprise Value	109,423	131,411	122,361	135,899	130,024	145,574
Last Close Price	4830.00	5860.00	5354.84	6085.51	5387.79	6171.41
PE Ratio	6.56	9.57	16.85	20.23	19.18	-
PS Ratio	0.62	0.78	0.77	0.92	0.92	1.32
PB Ratio	0.95	1.19	1.26	1.53	1.42	1.79
P/TBV Ratio	0.96	1.20	1.26	1.53	1.43	1.80
P/FCF Ratio	7.25	12.75	18.56	-	18.59	-
P/OCF Ratio	6.03	10.36	13.86	24.09	15.50	4220.66
EV/Sales Ratio	0.92	1.16	1.15	1.33	1.41	1.97
EV/EBITDA Ratio	6.53	8.80	10.97	13.67	14.16	62.51
EV/EBIT Ratio	8.62	12.18	17.76	22.64	23.96	-
EV/FCF Ratio	10.82	18.85	27.57	-	28.56	-
Debt / Equity Ratio	0.53	0.59	0.70	0.72	0.73	0.84
Debt / EBITDA Ratio	2.44	2.92	4.09	4.48	4.73	19.85
Debt / FCF Ratio	4.04	6.27	10.27	-	9.55	-
Net Debt / Equity Ratio	0.47	0.53	0.69	0.71	0.69	0.83
Net Debt / EBITDA Ratio	2.17	2.67	4.04	4.44	4.49	19.51
Net Debt / FCF Ratio	3.61	5.71	10.15	-40.84	9.06	-17.09
Asset Turnover	0.87	0.85	0.84	0.84	0.78	0.64
Inventory Turnover	3.65	3.87	4.34	4.60	4.98	4.60
Quick Ratio	0.66	0.64	0.56	0.59	0.71	0.76
Current Ratio	1.01	0.98	0.87	0.91	1.06	1.08
Return on Equity (ROE)	15.57%	13.25%	7.54%	7.64%	7.62%	-2.61%
Return on Assets (ROA)	5.80%	5.05%	3.39%	3.06%	2.88%	-0.72%
Return on Invested Capital (ROIC)	10.29%	9.08%	5.95%	5.80%	5.40%	-1.35%
Return on Capital Employed (ROCE)	16.00%	14.00%	9.80%	8.30%	6.90%	-1.70%
Earnings Yield	15.22%	10.45%	5.93%	4.94%	5.21%	-1.51%
FCF Yield	13.80%	7.84%	5.39%	-1.14%	5.38%	-2.72%
Payout Ratio	8.16%	9.80%	18.62%	16.21%	-	-
Buyback Yield / Dilution	0.29%	0.07%	-0.07%	-	-	-
Total Shareholder Return	1.48%	0.07%	-0.07%	-	-	-